Beryl Drugs Limited (BSE: 524606)
Health Care · Pharmaceuticals · IN
Rs22.80
-0.65% today · +0.2% 1Y
Beryl Drugs Limited (BSE: 524606) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.21M.
Over the last twelve months the share price has gained 0.2%, trading between 15.92 and 30.00.
Tweenvest scores Beryl Drugs Limited across four factors: quality 62/100, value 53/100, growth 0/100. Its strongest factor is quality.
524606 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.21M
- Revenue (TTM)
- $2.26M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- Rs30.00
- 52-week low
- Rs15.92
- Avg volume (3M)
- —
- Shares outstanding
- 5.07M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,232.30 | -1.17% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.40 | +3.81% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.52 | +1.97% |
Figures last refreshed Aug 18, 2026.